Business Update Neutral

2026-08-26 17:16

- Investor Meeting Schedule - Date: August 31, 2026 - Investor/Analyst: ITUS Capital - Type: Virtual One-on-One - No unpublished price sensitive information will be shared.

Business Update Neutral

2026-08-19 17:41

- PI Industries Limited will interact with analysts/investors on the following dates: - August 25, 2026, with Kotak Mahindra Asset Management Company (Virtual, One-on-One) - August 31, 2026, with Quest Investments (Mumbai, One-on-One) - September 04, 2026, with Awriga Capital (Mumbai, One-on-One) - No unpublished price sensitive information is proposed to be shared during these meetings.

Business Update Neutral

2026-08-19 17:39

- Investor Meetings Scheduled: - August 25, 2026: One-on-one meeting with Kotak Mahindra Asset Management Company (Virtual). - August 31, 2026: One-on-one meeting with Quest Investments (Mumbai). - September 04, 2026: One-on-one meeting with Awriga Capital (Mumbai). - No unpublished price sensitive information is proposed to be shared.

Business Update Neutral

2026-08-19 17:35

- Analyst/Investor Interactions Scheduled: - August 25, 2026: Kotak Mahindra Asset Management Company (Virtual, One-on-One) - August 31, 2026: Quest Investments (Mumbai, One-on-One) - September 04, 2026: Awriga Capital (Mumbai, One-on-One) - No Unpublished Price Sensitive Information (UPSI) will be shared.

Business Update Positive

2026-08-18 20:42

- The company reported Q1 FY27 Revenue of ₹17,023 million with a gross margin of 57% and EBITDA of 22% (₹3,693 million). - FY27 revenue growth guidance is in the lower single digits, with an expected Effective Tax Rate (ETR) of around 24%. - Capex guidance for FY27 is ₹700-₹800 crore. - Management expects FY27 to be better than FY26, driven by recovery in exports in H2, new product launches, and gradual scale-up of pharma and global biologicals businesses. - Biologicals business showed 50% aggressive growth in Q1, with a 3-year CAGR of 15%, and is launching new nematicide products in Brazil, Mexico, and the US (Brazil market estimated at ~USD 750 million). - New NCE, Pioxaniliprole (an insecticide), is expected to launch in the domestic market this year, with plans for other geographies later. Dicloromezotiaz is also launching this season with long-term 3-digit revenue potential in India. - Strategic investments in new businesses like Pharma (CRDMO) and Global Biologicals are leading to current subsidiary losses (approx. ₹100 crore EBITDA loss in Q1) but are considered vital for future long-term growth and value creation. - The company maintains a strong, debt-free balance sheet with ₹38 billion in net cash, and reduced net working capital by 19 days, releasing ₹300 crore in cash. - Electronic and specialty chemicals segment shows continued trajectory with new queries and commercialization, with commercial supplies now started with new technology.

Governance Neutral

2026-08-14 18:20

CRITICAL RED FLAG DETECTED

- PI Industries' 79th AGM held August 14, 2026. - Total dividend of ₹15.00 per share for FY26 declared. - Mr. Rajnish Sarna stepped down as JMD, continues as Non-executive Director. - Mr. Arvind Singhal did not seek re-appointment as Non-Executive Director.

Business Update Neutral

2026-08-13 18:41

- Investor/Analyst Interactions Scheduled - Date & Firm (1): August 19, 2026 with DSP Asset Managers (Mumbai, One-on-One) - Date & Firm (2): August 24, 2026 with Capital World (Virtual, One-on-One) - No unpublished price sensitive information will be shared during these meetings.

Business Update Neutral

2026-08-13 18:30

- Investor/Analyst Interactions Scheduled - Concall Date: August 19, 2026 - Concall Type: One-on-One meeting with DSP Asset Managers (Mumbai) - Concall Date: August 24, 2026 - Concall Type: One-on-One virtual meeting with Capital World - No unpublished price sensitive information will be shared.

Business Update Neutral

2026-08-12 16:47

- Investor Meet Schedule - Date: August 19, 2026 - Event: Motilal Oswal 22nd Annual Global Investor Conference, 2026 - Meeting Type: Mix of One-on-One and Group Meetings

Business Update Neutral

2026-08-12 16:39

- Audio recording of the Earnings Conference Call for the quarter ended June 30, 2026, is available on the company's website. - The conference call was held on Wednesday, August 12, 2026.

Financials Negative

2026-08-11 21:21

- Q1 FY27 Consolidated Revenue ₹1,702.3Cr vs ₹1,900.5Cr (▼10% YoY) - EBITDA ₹369.3Cr vs ₹521.9Cr (▼29% YoY) - PAT ₹244.2Cr vs ₹400Cr (▼39% YoY) - EBITDA Margin 22% vs 27% (▼577bps) - Domestic Biologicals grew 50%+ YoY in Q1FY27 - Commercialized 3 new molecules in Exports and launched a new peptide-based Biological product in the US - Trade Working Capital reduced by 19 Days to 120 Days in Jun-26 - Net Cash balance increased to INR 37,939 Mn

Financials Negative

2026-08-11 19:35

- Q1 FY27 Consolidated Revenue ₹1,702.3Cr vs ₹1,900.5Cr (▼10.43% YoY) - EBITDA ₹369.3Cr vs ₹521.9Cr (▼29.24% YoY) - PAT ₹244.2Cr vs ₹400.0Cr (▼38.95% YoY) - EBITDA Margin 21.69% vs 27.46% (▼577bps)

Financials Negative

2026-08-11 19:23

- Q1 FY27 Consolidated Revenue ₹17,023Mn vs ₹19,005Mn (▼10.43% YoY) - EBITDA ₹4,334Mn vs ₹6,078Mn (▼28.70% YoY) - PAT ₹2,442Mn vs ₹4,000Mn (▼38.95% YoY) - EBITDA Margin 25.46% vs 31.98% (▼652bps) - The Board approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. - The Board also approved the incorporation of 'PI Foundation' as a Wholly Owned Subsidiary of the Company.

Financials Negative

2026-08-11 19:07

- Q1 FY27 Consolidated Revenue ₹1,702.3Cr vs ₹1,900.5Cr (▼10.43% YoY) - EBITDA ₹369.3Cr vs ₹521.9Cr (▼29.24% YoY) - PAT ₹244.2Cr vs ₹400.0Cr (▼38.95% YoY) - EBITDA Margin 21.69% vs 27.46% (▼577bps)

Business Update Neutral

2026-08-03 19:16

- Concall Schedule - Concall Date: August 12, 2026 - Concall Time: 12:00 noon IST

Governance Neutral

2026-08-03 19:13

- Board Meeting on August 11, 2026, to approve unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. - Trading window closed from July 1, 2026, to August 13, 2026.

Governance Neutral

2026-07-21 17:41

- PI Industries Ltd. has intimated the scheduling of its 79th Annual General Meeting (AGM) on August 14, 2026, at 10:30 A.M. IST via Video Conferencing/Other Audio-Visual Means. - Shareholders are informed about accessing the Notice of AGM and the Integrated Annual Report for FY 2025-26 electronically.

Financials Positive

2026-07-20 15:23

- Integrated Annual Report for the financial year 2025-26 submitted. - 79th Annual General Meeting (AGM) scheduled for August 14, 2026, at 10:30 a.m. (IST) via VC/OAVM. - Record Date for determining dividend entitlement fixed as August 7, 2026. - Final dividend of ₹10/- per equity share proposed for FY 2025-26, subject to AGM declaration.

Routine Negative

2026-07-20 15:13

CRITICAL RED FLAG DETECTED

- Filed Business Responsibility and Sustainability Report (BRSR) for FY 2025-26, as per SEBI (LODR) Regulations. - The report details the company's sustainability initiatives, governance frameworks, and ESG performance. - A monetary penalty of ₹30.03 lakhs was imposed by the Excise and Taxation Officer for FY 2021-22 (GST input tax credits), which is currently under dispute.

Governance Positive

2026-07-20 14:57

- Submission of Integrated Annual Report for FY 2025-26. - 79th Annual General Meeting (AGM) scheduled for August 14, 2026, at 10:30 a.m. (IST). - Record Date for dividend entitlement is August 7, 2026. - Final dividend of ₹10/- per equity share for FY 2025-26 proposed, subject to AGM approval.

Financials Positive

2026-07-16 19:36

- 79th Annual General Meeting (AGM) scheduled for August 14, 2026. - Record Date for final dividend of ₹10/- per equity share for FY 2025-26 is August 7, 2026.

Governance Positive

2026-07-16 19:28

- 79th Annual General Meeting (AGM) of the Company is scheduled for Friday, August 14, 2026. - The Record Date for determining entitlement to receive the final dividend of ₹10/- per equity share for FY 2025-26 is Friday, August 7, 2026.

Routine Neutral

2026-06-26 14:58

- Intimation for closure of trading window for designated persons. - Effective from July 1, 2026, until 48 hours after Q1 FY27 results. - Ahead of unaudited standalone and consolidated financial results for the quarter ending June 30, 2026.

Business Update Positive

2026-06-23 19:39

- PI Industries' Board approved converting ₹10,000 Cr Optionally Fully Convertible Debentures (OFCDs) held in its wholly-owned subsidiary, PI Health Sciences Limited (PIHS), into 72.46 Cr equity shares at ₹13.80/share. The conversion aims to strengthen the consolidated balance sheet and involves no cash.

Business Update Positive

2026-06-23 19:39

- PI Industries' Board approved the conversion of ₹10,000 million worth of Optionally Fully Convertible Debentures (OFCDs) held in its wholly-owned subsidiary, PI Health Sciences Limited (PIHS), into 72,46,37,681 equity shares at ₹13.80/share. - This conversion strengthens the consolidated balance sheet and does not alter the ownership or control of PIHS, which remains a wholly-owned subsidiary.

Business Update Neutral

2026-06-18 16:10

- The company has scheduled interactions with Analysts/Investors. - June 23, 2026: One-on-one meetings with Ellerston Capital (Virtual) and JM Financial Institutional Securities (Mumbai). - June 25-26, 2026: Investor meetings in Singapore (mix of one-on-one and group). - No unpublished price sensitive information will be shared during these meetings.

Business Update Neutral

2026-06-18 16:06

- Intimation of interactions with Analysts/Investors as per Regulation 30(6) of SEBI (LODR) Regulations, 2015. - Meetings scheduled for June 23, 2026, with Ellerston Capital (Virtual) and JM Financial Institutional Securities (Mumbai). - Additional investor meetings scheduled for June 25 and June 26, 2026, in Singapore. - No unpublished price sensitive information will be shared during these meetings.

Business Update Neutral

2026-06-18 16:04

- PI Industries will interact with analysts/investors from Ellerston Capital, JM Financial, and other investors on June 23, 25, and 26, 2026, in one-on-one and group formats. No price sensitive information will be shared.

Business Update Neutral

2026-06-16 17:56

- PI Industries Limited will be interacting with analysts/investors on June 22, 2026. - Scheduled one-on-one meetings with Enam AMC, ADD Capital, Capital Group (London), and Franklin Templeton MF. - No unpublished price sensitive information is proposed to be shared.

Business Update Neutral

2026-06-11 13:23

- Investor/Analyst Meetings Scheduled - Meeting Date: June 16, 2026 - Participants: Nuvama Institutional Equities, Keynote Financial Services Ltd. - No unpublished price sensitive information will be shared.

Business Update Neutral

2026-06-02 15:48

- PI Industries Limited will hold one-on-one interactions with Morgan Stanley on June 5, 2026, and Bank of America Securities on June 12, 2026, both in Mumbai. No unpublished price sensitive information will be shared.

Business Update Neutral

2026-06-02 15:45

- Investor Interactions Scheduled - June 5, 2026: One-on-One meeting with Morgan Stanley in Mumbai. - June 12, 2026: One-on-One meeting with Bank of America Securities in Mumbai. - No unpublished price sensitive information will be shared during these meetings.

Routine Neutral

2026-05-27 16:27

PI Industries Limited submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report, issued by M/s. Makarand M. Joshi & Co., confirms that the company has complied with applicable SEBI Regulations and circulars/guidelines. No significant non-compliances, actions by SEBI or Stock Exchanges, or resignations of statutory auditors were observed during the review period.

Business Update Neutral

2026-05-26 16:23

PI Industries Limited has intimated about upcoming interactions with analysts and investors. The company will hold one-on-one meetings in Mumbai with Matthews International Capital Management on May 31, 2026, ICICI Prudential Asset Management Company on June 01, 2026, and ithought PMS on June 09, 2026. No unpublished price sensitive information is proposed to be shared during these meetings.

Business Update Neutral

2026-05-26 16:20

PI Industries Limited will hold one-on-one interactions with investors/analysts from Matthews International Capital Management (May 31, 2026), ICICI Prudential Asset Management Company (June 01, 2026), and ithought PMS (June 09, 2026) in Mumbai. No unpublished price sensitive information will be shared during these meetings.

Business Update Neutral

2026-05-26 16:18

PI Industries Limited announced its schedule for interactions with analysts and institutional investors under Regulation 30(6) of SEBI (LODR) Regulations. The company will hold one-on-one meetings on May 31, June 01, and June 09, 2026, with Matthews International Capital Management, ICICI Prudential Asset Management Company, and ithought PMS, respectively, in Mumbai. The company confirmed that no unpublished price sensitive information will be shared during these meetings.

Business Update Positive

2026-05-26 13:19

CRITICAL RED FLAG DETECTED

PI Industries reported FY26 consolidated revenue of ₹67,137 million with a healthy 25% EBITDA margin, supported by 40% growth in Pharma and over 20% in Biologicals, maintaining a debt-free balance sheet. For FY27, management guided for positive revenue growth, driven by recovery in AgChem exports (H2 FY27) and new product launches, including their first homegrown NCE, Pioxaniliprole. Capex is projected at ₹700-800 crore. The company targets ₹500-600 crore top line for Pharma to turn EBITDA positive in 2-3 years and $100 million revenue from Electronic Chemicals in 4-5 years, alongside significant growth from new biological products. Rajnish Sarna stepped down as JMD for health reasons but continues as a Non-Executive Director.

Business Update Neutral

2026-05-25 12:54

PI Industries Limited announced upcoming interactions with analysts and investors. The company will participate in the Axis Capital Rising Stars Conference 2026 on June 1, 2026, and Citi's 2026 India Conference on June 5, 2026. These meetings will include one-on-one and group interactions at Grand Hyatt, Mumbai. The company confirmed that no unpublished price sensitive information will be shared.

Business Update Neutral

2026-05-25 12:51

PI Industries Limited will hold interactions with analysts and investors at the Axis Capital Rising Stars Conference 2026 on June 1, 2026, and Citi's 2026 India Conference on June 5, 2026. Both events will take place at Grand Hyatt, Mumbai, involving a mix of one-on-one and group meetings. The company has stated that no unpublished price sensitive information will be shared during these interactions.

Ownership Positive

2026-05-22 09:57

ICICI Prudential Mutual Fund increased its shareholding in PI Industries Ltd. through open market acquisitions. The Fund acquired a net of 30,90,753 shares between October 1, 2025, and May 20, 2026, including 4,38,842 shares on May 20, 2026. This increased their total holding from 5.120% (as per the October 1, 2025 disclosure) to 7.157% of the paid-up capital (1,08,58,536 shares). The acquisition is for investment purposes, not seeking controlling interest.

Routine Neutral

2026-05-21 18:34

New Filing detected. See link for details.

Business Update Neutral

2026-05-20 17:51

PI Industries Limited announced the audio recording of its Earnings Conference Call with Analysts and Investors, held on May 20, 2026. The call discussed the Audited Standalone & Consolidated Financial Results for the quarter and financial year ended March 31, 2026. The recording is available on the company's website for investor access.

Financials Negative

2026-05-19 23:31

CRITICAL RED FLAG DETECTED

Standalone Revenue ₹13,914Mn vs ₹16,482Mn (▼15.58% YoY), EBITDA ₹3,852Mn vs ₹5,039Mn (▼23.56% YoY), PAT ₹1,978Mn vs ₹3,858Mn (▼48.73% YoY). EBITDA Margin 27.68% vs 30.57% (▼289bps). The Board also recommended a final dividend of Rs. 10/- per share, bringing the total dividend for FY26 to Rs. 15/- per share. An impairment loss of ₹1,100 million was recognized as an exceptional item. Mr. Arvind Singhal, a Non-Executive, Non-Independent Director, will not seek re-appointment and will retire at the ensuing AGM.

Governance Neutral

2026-05-19 21:55

PI Industries Limited announced that its Board has authorized Dr. Atul Kumar Gupta (Whole-Time Director), Mr. Sanjay Agarwal (Group Chief Financial Officer and Head - Strategy and Integrated Development Cell), and Ms. Shruti Joshi (Company Secretary and Compliance Officer) as Key Managerial Personnel. These KMPs are empowered to determine the materiality of an event or information and to make appropriate disclosures to the Stock Exchanges, as per Regulation 30(5) of SEBI Listing Regulations.

Financials Negative

2026-05-19 21:45

CRITICAL RED FLAG DETECTED

Standalone Revenue ₹1,391.4Cr vs ₹1,648.2Cr (▼16% YoY), EBITDA ₹273.5Cr vs ₹503.9Cr (▼46% YoY), PAT ₹197.8Cr vs ₹385.8Cr (▼49% YoY). EBITDA Margin 20% vs 31% (▼1091bps). An exceptional impairment loss of ₹111.7Cr was recorded. A final dividend of ₹10/share was recommended, totaling ₹15/share for FY2025-26. Mr. Rajnish Sarna resigned as JMD but was re-designated as Non-Executive, Non-Independent Director. Mr. Arvind Singhal, Non-Executive, Non-Independent Director, will retire and not seek re-appointment.

Financials Negative

2026-05-19 21:38

CRITICAL RED FLAG DETECTED

Standalone Revenue ₹1391.4Cr vs ₹1648.2Cr (▼15.58% YoY), EBITDA ₹456.3Cr vs ₹572.1Cr (▼20.23% YoY), PAT ₹197.8Cr vs ₹385.8Cr (▼48.73% YoY). EBITDA Margin 32.79% vs 34.71% (▼192bps). The company also recommended a final dividend of Rs. 10/- per share for FY2025-26, bringing the total dividend to Rs. 15/- per share for the year.

Financials Negative

2026-05-19 21:34

CRITICAL RED FLAG DETECTED

Standalone Revenue ₹13,914Mn vs ₹16,482Mn (▼15.6% YoY), EBITDA ₹3,852Mn vs ₹5,039Mn (▼23.6% YoY), PAT ₹1,978Mn vs ₹3,858Mn (▼48.7% YoY). EBITDA Margin 27.7% vs 30.6% (▼290bps). Additionally, the Board recommended a final dividend of ₹10/- per share for FY26, bringing the total to ₹15/-. Mr. Rajnish Sarna resigned as Joint Managing Director, and the company recognized a ₹1,100Mn impairment provision on an equity investment in a subsidiary due to business losses.

Financials Negative

2026-05-19 21:27

CRITICAL RED FLAG DETECTED

Standalone Revenue ₹1,391.4 Cr vs ₹1,648.2 Cr (▼15.6% YoY), EBITDA ₹273.5 Cr vs ₹503.9 Cr (▼45.7% YoY), PAT ₹197.8 Cr vs ₹385.8 Cr (▼48.7% YoY). EBITDA Margin 19.66% vs 30.57% (▼1091bps). The Board also recommended a final dividend of ₹10/- per share, making the total dividend for FY26 ₹15/- per share. Mr. Rajnish Sarna resigned as Joint Managing Director but was re-designated as Non-Executive, Non-Independent Director, and Mr. Arvind Singhal (Non-Executive, Non-Independent Director) will retire at the AGM.

Financials Negative

2026-05-19 21:23

CRITICAL RED FLAG DETECTED

PI Industries Limited reported Standalone financial results for Q4 FY26. Standalone Revenue ₹13,914Mn vs ₹16,482Mn (▼15.58% YoY), EBITDA ₹3,852Mn vs ₹5,039Mn (▼23.56% YoY), PAT ₹1,978Mn vs ₹3,858Mn (▼48.73% YoY). EBITDA Margin 27.68% vs 30.57% (▼289bps). The Board recommended a final dividend of ₹10 per share, making the total dividend for FY26 ₹15 per share. Mr. Rajnish Sarna resigned as Joint Managing Director but was re-designated as Non-Executive, Non-Independent Director. The company recognized a significant provision of ₹1,100 million for impairment on an equity investment due to business losses. Various director appointments/re-appointments and cost auditor re-appointment were also approved.

Financials Negative

2026-05-19 21:06

CRITICAL RED FLAG DETECTED

Standalone Revenue ₹13,914Mn vs ₹16,482Mn (▼15.6% YoY), EBITDA ₹3,852Mn vs ₹5,039Mn (▼23.6% YoY), PAT ₹1,978Mn vs ₹3,858Mn (▼48.7% YoY). EBITDA Margin 27.7% vs 30.6% (▼290bps). The results were impacted by an exceptional impairment loss of ₹1,117Mn on an equity investment. The Board recommended a final dividend of ₹10/- per share. Mr. Rajnish Sarna resigned as Joint Managing Director but was re-designated as Non-Executive, Non-Independent Director.

523642

PI Industries Ltd

Price Chart

Filing History

Unlock Full History